Skip to content

Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)

Constitution of a Collection of Residues of Neuromuscular Biopsies From Patients Taken as Part of Their Health Care at the Bordeaux University Hospital for Neuromuscular Disease and Use for Research Projects

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06074822
Acronym
COLMYONEU
Enrollment
500
Registered
2023-10-10
Start date
2023-06-26
Completion date
2053-06-25
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle, Nerve, Neuromuscular Diseases

Brief summary

Neuromuscular diseases are rare diseases for which significant progress has been made in the context of diagnosis thanks to advances in molecular techniques, but the intimate mechanisms of lesion formation remain poorly understood. Advances in cellular and molecular biology, the development of a few animal models, such as transgenic mice, which make it possible to mimic human pathology have made it possible to better understand the physiopathology of these diseases. However, they still do so very imperfectly and incompletely, making it even more necessary than ever to study diseased human muscle tissue to find new avenues of research or to confirm results obtained by experimentation. The purpose of this collection of tissue samples for neuro-muscular purposes is to collect such samples under the best conditions in order to promote basic and translational research on muscle diseases. This is why the CHU de Bordeaux wishes to keep the remainders of samples taken as part of the treatment to constitute a collection of biological samples and associated data kept according to quality standards and in compliance with the regulations in force.

Detailed description

The COLMYONEU project is a project to collect leftover frozen neuromuscular biopsy samples from patients taken as part of their health care at the Bordeaux University Hospital for neuromuscular disease. Its main objective is to store, under the conditions of the CRB standard, residual biological samples from patients with neuromuscular symptoms.

Interventions

OTHERResidual neuromuscular biopsy

recovery of residual neuromuscular biopsy (nerve ans muscle)

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients treated at Bordeaux University Hospital (neurology services, neuropediatrics), rheumatology, medical genetics for suspected neuromuscular disease. * Men and women are affected, adults and minors.

Exclusion criteria

\- no

Design outcomes

Primary

MeasureTime frameDescription
Constitution of a biocollection30 yearsCollection of leftover frozen neuromuscular biopsy samples from patients taken as part of their health care at the Bordeaux University Hospital for neuromuscular disease.

Countries

France

Contacts

Primary ContactMarie Laure NEGRIER, Pr
marie-laure.martin-negrier@chu-bordeaux.fr0557821818
Backup ContactGuilhem SOLE, Dr
guilhem.sole@chu-bordeaux.fr0557821818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026